$13.69
-1.22 (-8.18%)
Open$15.50
Previous Close$14.91
Day High$16.05
Day Low$13.69
52W High$46.95
52W Low$13.69
Volume—
Avg Volume203.3K
Market Cap93.50M
P/E Ratio—
EPS$-30.96
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.55M | 28.2K | 2.72M |
| Net Income | -211,449,798 | -1,181,711 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -237,343,199 | -1,400,261 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | — | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |